In this podcast senior researcher at the Westmead Institute for Medical Research, Dr Thomas Tu discusses the latest developments in hepatitis B presented at this year’s GESA scientific meeting – from new treatments under development that bring the promise of cure closer to public health viral elimination strategies.

And Dr Avik Majumdar, transplant hepatologist at the Royal Prince Alfred Hospital in Sydney shares his highlights from the Liver stream discussing new data identifying sub groups and prognosis in decompensated cirrhosis, new treatment developments in primary sclerosing cholangitis as well as the increasing role of non-invasive evaluation on prognosis in liver disease.